Clinical characteristics of initial recurrence in lung after surgical resection for pancreatic ductal adenocarcinoma
- PMID: 32900632
- DOI: 10.1016/j.pan.2020.08.019
Clinical characteristics of initial recurrence in lung after surgical resection for pancreatic ductal adenocarcinoma
Abstract
Background: The clinical characteristic differences at the initial recurrence site after resection for pancreatic ductal adenocarcinoma (PDAC) remain unknown. We investigated the clinical characteristics in patients with lung recurrence after surgical resection and evaluated the outcome of resection for isolated lung recurrence.
Methods: Of 442 consecutive PDAC patients who underwent surgical resection between 2002 and 2018, 229 had recurrence on imaging. Initial recurrence sites were the liver, lung, local, peritoneal, multiple organs, and others. We analyzed the clinicopathologic factors and outcomes, comparing by initial recurrence site, and investigated the outcomes of resection for isolated lung recurrence.
Results: Liver recurrences were the most frequent (n = 60, 26%), followed by lung recurrence (n = 48, 21%). The interval from surgery to recurrence was significantly longer in lung recurrence (P = 0.0001). Patients with lung recurrence had significantly longer overall survival after diagnosis (P < 0.0001). Patients who underwent surgical resection of lung recurrence had a significantly prolonged overall survival rate after recurrence diagnosis (P = 0.004).
Conclusions: Patients with lung recurrence had significantly prolonged survival than those with other recurrence patterns. Resection for isolated lung recurrence represented relatively good prognosis, and possibly may be beneficial in highly-selected patients.
Keywords: Lung; Lung recurrence; Pancreatic cancer; Pancreatic ductal adenocarcinoma; Pulmonary metastasis.
Copyright © 2020 IAP and EPC. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflicts of interest None.
Similar articles
-
Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?World J Surg Oncol. 2014 Nov 18;12:347. doi: 10.1186/1477-7819-12-347. World J Surg Oncol. 2014. PMID: 25407113 Free PMC article.
-
Meta-analysis of recurrence pattern after resection for pancreatic cancer.Br J Surg. 2019 Nov;106(12):1590-1601. doi: 10.1002/bjs.11295. Epub 2019 Aug 27. Br J Surg. 2019. PMID: 31454073
-
Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection.J Gastrointest Surg. 2012 Sep;16(9):1696-704. doi: 10.1007/s11605-012-1912-8. Epub 2012 May 30. J Gastrointest Surg. 2012. PMID: 22644446 Free PMC article.
-
Isolated pulmonary recurrence after resection of pancreatic cancer: the effect of patient factors and treatment modalities on survival.HPB (Oxford). 2019 Aug;21(8):998-1008. doi: 10.1016/j.hpb.2018.12.002. Epub 2019 Feb 15. HPB (Oxford). 2019. PMID: 30777697
-
Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.World J Gastroenterol. 2017 Sep 21;23(35):6420-6428. doi: 10.3748/wjg.v23.i35.6420. World J Gastroenterol. 2017. PMID: 29085191 Free PMC article. Review.
Cited by
-
Stereotactic body radiation therapy for the primary tumor and oligometastases versus the primary tumor alone in patients with metastatic pancreatic cancer.Radiat Oncol. 2024 Aug 19;19(1):111. doi: 10.1186/s13014-024-02493-8. Radiat Oncol. 2024. PMID: 39160547 Free PMC article.
-
Surgical resection for liver recurrence after curative resection of pancreatic ductal adenocarcinoma.Langenbecks Arch Surg. 2023 Jul 17;408(1):280. doi: 10.1007/s00423-023-03009-w. Langenbecks Arch Surg. 2023. PMID: 37458812
-
Prognostic impact of lung recurrence in patients with biliary tract cancer.Langenbecks Arch Surg. 2023 Jul 31;408(1):290. doi: 10.1007/s00423-023-03015-y. Langenbecks Arch Surg. 2023. PMID: 37522989
-
The inhibition of pancreatic cancer progression by K-Ras-overexpressing mesenchymal stem cell-derived secretomes.Sci Rep. 2023 Sep 12;13(1):15036. doi: 10.1038/s41598-023-41835-6. Sci Rep. 2023. PMID: 37699930 Free PMC article.
-
Prognostic factor in patient with recurrent pancreatic adenocarcinoma.Langenbecks Arch Surg. 2023 Sep 2;408(1):347. doi: 10.1007/s00423-023-03073-2. Langenbecks Arch Surg. 2023. PMID: 37658871
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical